OrotLuces
Status
ACTIVE
Global HQ
Tel Aviv, Israel
Countries of investment
- Israel
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
Industries
- Health Tech
- Biotechnology
About
OrotLuces is a venture capital firm based in Tel Aviv, Israel, dedicated to supporting healthcare innovation by investing in early stage companies. With a focus on breakthrough technologies and therapies, the firm strives to make a meaningful impact on patient care. OrotLuces aims to help bring lifechanging solutions to market and improve healthcare outcomes worldwide. The firms platform is built on over four decades of experience in the healthcare field, with a proven track record of execution and favorable riskadjusted returns across different healthcare services and biotech companies.
OrotLuces is a venture capital firm based in Tel Aviv, Israel, dedicated to supporting healthcare innovation by investing in early stage companies. With a focus on breakthrough technologies and therapies, the firm strives to make a meaningful impact on patient care. OrotLuces aims to help bring lifechanging solutions to market and improve healthcare outcomes worldwide. The firms platform is built on over four decades of experience in the healthcare field, with a proven track record of execution and favorable riskadjusted returns across different healthcare services and biotech companies.
Investment Thesis
Our platform offers a favorable risk/reward profile and it’s the right place for exceptional entrepreneurs, companies and investors developing breakthrough technologies which will significantly impact cancer care.
Manager's Experience
With extensive experience in technology and consumer sectors, the fund manager has successfully executed over 30 deals across North America and Europe. Their operator-first approach emphasizes hands-on engagement with portfolio companies, ensuring value creation from the ground up. Notable exits include several high-profile acquisitions, reflecting a keen eye for market trends and growth potential. This strategic focus on early to growth-stage investments showcases their ability to navigate complex market dynamics effectively.